Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2001 October;49(5) > Minerva Cardioangiologica 2001 October;49(5):307-16

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints

 

REVIEWS   

Minerva Cardioangiologica 2001 October;49(5):307-16

Copyright © 2001 EDIZIONI MINERVA MEDICA

language: English, Italian

What drug must be used to avoid the most common hypertensive complications?

Cacciapuoti F.


PDF


After recalling that cardiovascular complications represent the most frequent cause of mortality and morbidity in hypertensive patients, the author describes the main mechanism responsible for increased plasma level concentrations of Angiotensin in this syndrome. He subsequently illustrates the effects of ACE-inhibitors, differentiating them from AT1-receptors. The anti-hypertensive actions of new b-blockers, like Carvedilol and Nebivolol are also explained. In addition, the anti brain hemorrhage and heart-failure effects of diuretics in hypertensive patients are briefly summarised. Finally, the anti-calcinotic effect and anti-embolic action of calcium-antagonist drugs are also underlined.

top of page